Coologics Secures $3+ Million in Oversubscribed Seed Funding RoundApril 27, 2025 Clinical-stage medical device company Coologics announces successful closing of seed funding round, exceeding initial target with strong investor confidence in their innovative product Vlisse for treating vaginal infections.